Advertisement

Strategies for Targeting Infection

  • John W. Babich
Chapter

Abstract

Currently the need to target infection has been driven by the need to visualize inflammation and infection in patients who do not present clinically with localizing symptoms. In this case, identification of site and causative agent is a critical step in implementing appropriate medical treatment. This is particularly critical in immune compromised patients, since signs and symptoms of infection may be minimized in patients with neutropenia (1). This review will focus on the targeted visualization of infection and inflammation, although such targeting may likely play a role in the delivery of therapeutic agents in the future.

Keywords

Imaging Agent Sterile Inflammation Chemotactic Peptide Target Infection Infection Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pizzo PA. Evaluation of fever in the patient with cancer. Eur J Cancer Clin Oncol 25:Suppl 2: S9–S16. 1989.Google Scholar
  2. 2.
    Lavender, J.P., Lowe, J., Barker, J.R., Burn, J.I., and Chaudri, M.A. Ga-67 citrate scanning in neoplastic and inflammatory disease. Br. J. Radiol. 44: 361–366, 1971.CrossRefGoogle Scholar
  3. 3.
    Peters, A..M., Saverymuttu, S.H. Reavy, H.J. Danpure, H.J. Osman, S., and Lavender, J.P. Imaging of inflammation with indium-111 tropolonate labeled leukocytes. J. Nucl. Med. 24 (1): 39–44, 1983.Google Scholar
  4. 4.
    Peters, A.M., Danpure, H.J., Osman, S., Hawker, R.J., Henderson, B.L., Hodgson, H.J., Kelly, J.D., Neirinckx, R.D., and Lavender, J.P. Clinical experience with 99m Tchexamethylpropyleneamineoxime for labeling leukocytes and imaging inflammation. Lancet 2: 946–949, 1986.CrossRefGoogle Scholar
  5. 5.
    Fischman, A.J., Rubin, R.H., Khaw, B.A., Callahan, R.J., Wilkinson, R., Keech, F., Dragotakes, S., Kramer, P., LaMuraglia, G.M., Lind, S., Strauss, H.W., Detection of acute inflammation with 1n-labeled non-specific polyclonal IgG. Semin. Nucl. Med. 18: 335–344, 1998.Google Scholar
  6. 6.
    Locher, J.T., Seybold, K., Andres, R.Y., and Schubiger, A. Imaging of inflammatory lesions after injection of radioiodinated monoclonal antigranulocyte antibodies. Nucl. Med. Commun. 7: 659–670, 1986.Google Scholar
  7. 7.
    Edwards, C.L., and Hayes, R.L. Tumor scanning with 67Ga citrate. J. Nucl. Med.. 10: 103–105, 1969.Google Scholar
  8. 8.
    Rennen HJ, Makarewicz J, Oyen WJ, Laverman P, Corstens FH, Boerman OC. The effect of molecular weight on nonspecific accumulation of (99m)T-labeled proteins in inflammatory foci. Nucl Med Biol 2001 May; 28 (4): 401–8Google Scholar
  9. 9.
    Rusckowski M, Qu T, Pullman J, Marcel R, Ley AC, Ladner RC, Hnatowich DJ. Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys. J Nucl Med 2000 Feb; 41 (2): 363–74Google Scholar
  10. 10.
    Snyderman, R. and Uhing, R.J. Chemoattractant stimulus-response coupling, in Inflammation: Basic Principles and Clinical Correlates. 2nd ed. Gallin, J.I., Goldstein, I.M., and Snyderman, R., Eds., Raven Press, New York, 1992, p. 421.Google Scholar
  11. 11.
    Srivastava, S.C. and Chervu, L.R. Radionuclide labeled red blood cells: Current status and future prospects. Semin. Nucl. Med. 14 (2): 68–82, 1984.CrossRefGoogle Scholar
  12. 12.
    Pressman, D., Day, E.D., and Blau, M. The use of paired labeling in the determination of tumor localizing antibodies. Cancer Res. 17: 845–850, 1957.Google Scholar
  13. 13.
    Kohler, G., and Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497, 1975.CrossRefGoogle Scholar
  14. 14.
    Becker W, Goldenberg DM,Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med 24 (2): 142–53, 1994CrossRefGoogle Scholar
  15. 15.
    Rubin, R.H., Young, L.S., Hansen, W.P., Nedelman, M., Wilkinson, R., Nelles, M.J., Callahan, R., Khaw, B.A., and Strauss, H.W. Specific and non-specific imaging of localized Fisher Immunotype I Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J. Nucl. Med. 29: 651–656, 1988.Google Scholar
  16. 16.
    Rubin, R.H., Fischman, A.J., Nedelman, M., Wilkinson, R., Callahan, R.J., Khaw, B.A., Hansen, W.P., Kramer, P.B., and Strauss, H.W. Radiolabeled non-specific polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with Ga-67-citrate and Tc-99m-labeled albumin. J. Nucl. Med. 30: 385–389, 1989.Google Scholar
  17. 17.
    Rubin RH Fischman AJ. The use of radiolabeled non-specific immunoglobulin in the detection of focal inflammation. Semin Nucl Med 24 (2): 169–79, 1994MathSciNetCrossRefGoogle Scholar
  18. 18.
    Torchilin VP. Polymeric contrast agents for medical imaging. Curr Pharm Biotechnol 2000 Sep; 1 (2): 183–215CrossRefGoogle Scholar
  19. 19.
    Morgan JR, Williams LA, Howard CB. Technetium-labelled liposome imaging for deep-seated infection. Br J Radiol 1985 Jan; 58 (685): 35–9CrossRefGoogle Scholar
  20. 20.
    Laverman P, Dams ET, Oyen WJ, Storm G, Koenders EB, Prevost R, van der Meer JW, Corstens FH, Boerman OC. A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. J Nucl Med 1999 40 (1): 192–7Google Scholar
  21. 21.
    van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, Claessens RA, van der Meer JW, Corstens FH. Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur J Nucl Med 1995 22 (11): 1249–55CrossRefGoogle Scholar
  22. 22.
    van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, Claessens RA, van der Meer JW, Corstens FH. Different behaviour of radioiodinated human recombinant interleukin-t and its receptor antagonist in an animal model of infection. Eur J Nucl Med 1996 23 (11): 1531–5CrossRefGoogle Scholar
  23. 23.
    Barrera P, van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van Lent PL, van de Putte LB, Corstens FH. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Rheumatology (Oxford) 2000 39 (8): 870–4CrossRefGoogle Scholar
  24. 24.
    Hay RV, Skinner RS, Newman OC, Kunkel SL, Lyle LR, Shapiro B, Gross MD. Scintigraphy of acute inflammatory lesions in rats with radiolabelled recombinant human interleukin-8. Nucl Med Commun 1997 18 (4): 367–78CrossRefGoogle Scholar
  25. 25.
    Van der Laken CJ, Boerman OC, Oyen WJ, Van de Ven MT, Ven der Meer JW, Corstens FH. The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation. Nucl Med Commun 1998 Mar; 19 (3): 271–81Google Scholar
  26. 26.
    Showell, H.J., Freer, R.J., Zigmond, S.H., Schiffman, E., Aswanikumar, S., Corcoran, B., and Becker, E.L. The structural relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J. Exp. Med. 143: 1154–1169, 1976CrossRefGoogle Scholar
  27. 27.
    Zogbhi, S.S., Thakur, M.L., and Gottschalk, A. A potential radioactive agent for labeling of human neutrophils. J. Nucl. Med. 22 (Abstr.): 32, 1981.Google Scholar
  28. 28.
    Fischman, A.J., Pike, M.C., Kroon, D., Fucello, A.J., Rexinger, D., ten Kate, C., Wilkinson, R., Rubin, R.H., and Strauss, H.W. Imaging of focal sites of bacterial infection in rats with I llIn-labeled chemotactic peptide analogs. J. Nucl. Med. 1991; 32: 483–491.Google Scholar
  29. 29.
    Fischman AJ, babich JW, Rubin RH. Infection imaging with Technetium-99m labeled chemotactic peptide analogs. Semin Nucl Med 24 (2): 154–68, 1994.CrossRefGoogle Scholar
  30. 30.
    van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, Edwards DS, Barrett JA, van der Meer JW, Corstens FH. Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation. J Nucl Med. 1997 Aug; 38 (8): 1310–5.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • John W. Babich
    • 1
  1. 1.Biostream, Inc.CambridgeUSA

Personalised recommendations